Clinical impact of COVID-19 in a single-center cohort of a prospective study in cancer patients receiving immunotherapy

Aim: Evaluating the incidence and course of COVID-19 in cancer patients treated with immunotherapy. Patients & methods: We reported the influenza-like illness events with diagnosis of COVID-19 within the patient cohort enrolled in the prospective observational multicenter INVIDIa-2 study in the single center of Parma. Results: Among 53 patients, eight experienced influenza-like illness during the influenza season 2019/2020, and three of them had diagnosis of COVID-19. They were males, elderly, with cardiovascular disease. Radiological features of COVID-19 pneumonitis were found in all of three cases, although the pharyngeal swab resulted positive in only two. Two of these three patients died due to respiratory failure. Conclusion: Cancer patients are at high risk of severe events from severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection.

[1]  F. André,et al.  Abstract CT403: Outcome of cancer patients infected with COVID-19, including toxicity of cancer treatments , 2020 .

[2]  S. Kanjilal,et al.  Influenza in the COVID-19 Era. , 2020, JAMA.

[3]  C. Finelli.  Obesity, COVID-19 and immunotherapy: the complex relationship! , 2020, Immunotherapy.

[4]  SeyedAhmad SeyedAlinaghi,et al.  Olfactory and gustatory dysfunctions due to the coronavirus disease (COVID-19): a review of current evidence , 2020, European Archives of Oto-Rhino-Laryngology.

[5]  V. Torri,et al.  COVID-19 in patients with thoracic malignancies (TERAVOLT): first results of an international, registry-based, cohort study , 2020, The Lancet Oncology.

[6]  D. Kerr,et al.  COVID-19 mortality in patients with cancer on chemotherapy or other anticancer treatments: a prospective cohort study , 2020, The Lancet.

[7]  T. Powles,et al.  Clinical Characteristics and Outcome for Four SARS-CoV-2-infected Cancer Patients Treated with Immune Checkpoint Inhibitors , 2020, European Urology.

[8]  B. Gyawali,et al.  COVID-19 and cancer: do we really know what we think we know? , 2020, Nature reviews. Clinical oncology.

[9]  C. Finelli.  Obesity and immunotherapy: the surprisingly positive association! , 2020, Immunotherapy.

[10]  G. Curigliano,et al.  The experience on coronavirus disease 2019 and cancer from an oncology hub institution in Milan, Lombardy Region , 2020, European Journal of Cancer.

[11]  M. Santillana,et al.  Patients with Cancer Appear More Vulnerable to SARS-CoV-2: A Multicenter Study during the COVID-19 Outbreak , 2020, Cancer discovery.

[12]  Hangyuan Guo,et al.  Risk factors of critical & mortal COVID-19 cases: A systematic literature review and meta-analysis , 2020, Journal of Infection.

[13]  Theodora Psaltopoulou,et al.  Hematological findings and complications of COVID‐19 , 2020, American journal of hematology.

[14]  Nicola Sverzellati,et al.  Integrated Radiologic Algorithm for COVID-19 Pandemic , 2020, Journal of thoracic imaging.

[15]  Heng Li,et al.  Coronavirus disease 2019 (COVID-19): current status and future perspectives , 2020, International Journal of Antimicrobial Agents.

[16]  C. Wang,et al.  Clinical characteristics of COVID-19-infected cancer patients: a retrospective case study in three hospitals within Wuhan, China , 2020, Annals of Oncology.

[17]  Ke Ma,et al.  Clinical characteristics of 113 deceased patients with coronavirus disease 2019: retrospective study , 2020, BMJ.

[18]  M. Chua,et al.  SARS-CoV-2 Transmission in Patients With Cancer at a Tertiary Care Hospital in Wuhan, China , 2020, JAMA oncology.

[19]  R. Lu,et al.  Detection of SARS-CoV-2 in Different Types of Clinical Specimens. , 2020, JAMA.

[20]  M. Bersanelli,et al.  Controversies about COVID-19 and anticancer treatment with immune checkpoint inhibitors , 2020, Immunotherapy.

[21]  J. Xiang,et al.  Clinical course and risk factors for mortality of adult inpatients with COVID-19 in Wuhan, China: a retrospective cohort study , 2020, The Lancet.

[22]  H. Rothan,et al.  The epidemiology and pathogenesis of coronavirus disease (COVID-19) outbreak , 2020, Journal of Autoimmunity.

[23]  G. Banna,et al.  Immunological insights on influenza infection and vaccination during immune checkpoint blockade in cancer patients. , 2020, Immunotherapy.

[24]  Heshui Shi,et al.  Evolution of CT Manifestations in a Patient Recovered from 2019 Novel Coronavirus (2019-nCoV) Pneumonia in Wuhan, China , 2020, Radiology.

[25]  Z. Fayad,et al.  CT Imaging Features of 2019 Novel Coronavirus (2019-nCoV) , 2020, Radiology.

[26]  Malik Peiris,et al.  Molecular Diagnosis of a Novel Coronavirus (2019-nCoV) Causing an Outbreak of Pneumonia , 2020, Clinical chemistry.

[27]  Victor M Corman,et al.  Detection of 2019 novel coronavirus (2019-nCoV) by real-time RT-PCR , 2020, Euro surveillance : bulletin Europeen sur les maladies transmissibles = European communicable disease bulletin.

[28]  Jedd D. Wolchok,et al.  Cancer immunotherapy using checkpoint blockade , 2018, Science.

[29]  D. Eibach,et al.  Performance of influenza case definitions for influenza community surveillance: based on the French influenza surveillance network GROG, 2009-2014 , 2017, Euro surveillance : bulletin Europeen sur les maladies transmissibles = European communicable disease bulletin.